Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy.
Sasson
M
M
Ronald O. Perelman Department of Dermatology, New York University Medical Center, NY 10016.
Stiller
M J
MJ
Shupack
J L
JL
Khasak
D
D
Karkoszka
J
J
Frenkel
K
K
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D007105:Immune Complex Diseases / Q000276:immunology / Q000628:therapy*; D015394:Molecular Structure; D010084:Oxidation-Reduction; D011565:Psoriasis / Q000276:immunology / Q000628:therapy*; D013936:Thymidine / Q000031:analogs & derivatives* / Q000276:immunology; D017186:Titrimetry; D014467:Ultraviolet Therapy
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; C018080:5-hydroxymethyl-2'-deoxyuridine; D013936:Thymidine